Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meridol regimen for dental plaque and gingivitis
NCT06240481Phase 3Completed
- Sponsor
- Colgate-Palmolive
- Start
- Sep 2024
- Primary completion
- Dec 2024
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Meridol in dental plaque and gingivitis (2 arms), sponsored by Colgate-Palmolive. Primary endpoints: Quigley and Hein Plaque Index (Turesky Modification) at 12 weeks and Loe and Silness Gingival Index at 12 weeks. Started Sep 2024; status: completed.
02
Drugs
Meridol
03
Conditions
dental plaquegingivitis
Beyond the preview
Go deeper on NCT06240481.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06240481.